Fig. 1From: Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer modelClearance profiles of select organs: Blood, liver, spleen, thymus, kidneys, and tumor (note that the y-axis is presented on a logarithmic scale)Back to article page